Connect your AI

Innoviva, Inc. INVA Retained Earnings

Retained Earnings at other companies

PfizerPFE

$117.24B-2.0%

Merck & Co.MRK

$66.72B+0.9%

AbbVieABBV

-$17.87B-87.6%

InsmedINSM

-$5.8B-25.6%

ArriVent BioPharma, Inc.AVBP

-$447.96M-48.0%

SavaraSVRA

——

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s retained earnings?: Innoviva, Inc. (INVA) reported retained earnings of $455.96M in Q1 2026.
How has Innoviva, Inc.'s retained earnings changed year-over-year?: Innoviva, Inc.'s retained earnings increased by 1042.4% year-over-year, from -$48.38M to $455.96M.
What is the long-term trend for Innoviva, Inc.'s retained earnings?: Over 5 years (2020 to 2025), Innoviva, Inc.'s retained earnings has grown at a -17.9% compound annual growth rate (CAGR), from -$722M to $269.37M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.